4-(2-(4-Nitro-1H-imidazol-1-yl)ethyl)morpholine

Catalog No. :
ACMJPK796
CAS No. :
6497-78-5
Molecular Formula :
C9H14N4O3
Molecular Weight :
226.24

IUPAC Name:4-(2-(4-nitro-1H-imidazol-1-yl)ethyl)morpholine

4-(2-(4-Nitro-1H-imidazol-1-yl)ethyl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$113.00Login to see priceIn stockInquiry
100mg99%$192.00Login to see priceIn stockInquiry
250mg99%$345.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-(4-Nitro-1H-imidazol-1-yl)ethyl)morpholine
IUPAC Name4-(2-(4-nitro-1H-imidazol-1-yl)ethyl)morpholine
Molecular FormulaC9H14N4O3
Molecular Weight226.24
SMILESO=[N+](C1=CN(CCN2CCOCC2)C=N1)[O-]
InChI KeyVDZAAIIQCHGJAD-UHFFFAOYSA-N
Synonym4-(2-(4-NITRO-1H-IMIDAZOL-1-YL)ETHYL)MORPHOLINE;RGW 611; RGW611; RGW-611;RGW 611;RGW 611 4-(2-(4-NITRO-1H-IMIDAZOL-1-YL)ETHYL)MORPHOLINE;RGW 611, 6497-78-5;Morpholine,4-[2-(4-nitro-1H-imidazol-1-yl)ethyl]-;RGW 611,inhibit,Inhibitor,RGW-611,RGW611;RGW 611, 10 mM in DMSO
CAS No.6497-78-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H320-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMJPK796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQNUW231 route compound structure diagram
    ACQNUW2313034-38-6 In Stock
  4. Then
  5. ACMJPK796 route product structure diagram
    ACMJPK7966497-78-5 In Stock
Inquiry

2. ACMJPK796 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMJPK796 route product structure diagram
    ACMJPK7966497-78-5 In Stock
Inquiry

Comments (0)